Colorectal cancer recurrent
Information
- Disease name
- Colorectal cancer recurrent
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02390947 | Completed | Phase 3 | Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT） | January 2015 | July 2019 |
| NCT06271980 | Completed | Early-Onset Colorectal Cancer Recurrence | April 15, 2023 | February 1, 2024 | |
| NCT01762293 | Completed | Phase 2 | A Study of Famitinib in Patients With Advanced Colorectal Cancer | April 2012 | October 2014 |
| NCT04368507 | Completed | Phase 1/Phase 2 | To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients | August 9, 2019 | December 21, 2021 |
| NCT06314971 | Recruiting | Predicting Local and Distant Recurrence in T1 Colorectal Cancer | March 15, 2023 | March 15, 2025 | |
| NCT06229340 | Recruiting | Phase 2 | Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations | October 3, 2023 | October 1, 2026 |
| NCT06314958 | Recruiting | Stage II/III Colorectal Cancer Recurrence | March 15, 2023 | March 15, 2025 | |
| NCT04067986 | Unknown status | Phase 1/Phase 2 | Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer | August 20, 2019 | October 31, 2021 |